Demographic and societal impact of Alzheimer’s in China will grow exponentially if its current course is not averted, according to pioneer in tau pathology, a hallmark of Alzheimer’s Disease A new treatment targeting tau pathology is tomorrow’s hope for a brighter future, and Phase 3 clinical studies are bringing us closer to that goal.

Dundee Corporation maintains 5% stake in company developing a revolutionary treatment for Alzheimer’s Disease.

Major Conference in Poland will Spotlight TauRx Therapeutics as an Example of International Entrepreneurial Success in Life Science